ABILIFY MYCITE (aripiprazole tablets with sensor) is a drug-device combination product comprised of Otsuka’s oral aripiprazole tablets embedded with an Ingestible Event Marker (IEM) sensor. The ABILIFY MYCITE System includes: ABILIFY MYCITE, the MYCITE® Patch (wearable sensor); the MYCITE APP (a smartphone application); and web-based portals for healthcare providers and caregivers1 The
The MYCITE system demonstrated no improvements in patient adherence whatsoever during the 5 years it was available. It was discontinued in 2022 because obviously it’s more expensive than regular aripiprazole and doesn’t get patients to actually take it.
Genuine opinion: We should be putting lithium in the water supply.
APPROVED!
The MYCITE system demonstrated no improvements in patient adherence whatsoever during the 5 years it was available. It was discontinued in 2022 because obviously it’s more expensive than regular aripiprazole and doesn’t get patients to actually take it.
Genuine opinion: We should be putting lithium in the water supply.